Journal article
A single center randomized trial assessing use of a vascular hemostasis device vs. conventional manual compression following ptca: What are the potential resource savings?
Abstract
We undertook a randomized controlled trial comparing VasoSeal, a collagen vascular hemostasis device (VHD), with manual compression to assess its role and potential cost savings in the PTCA population. Of 460 patients, 359 were excluded due to clinical instability (30%), groin problems (18%), suboptimal PTCA result (15%), and other reasons (37%). The remaining 101 patients were randomized to either VHD (51) or manual compression (50). …
Authors
Slaughter PMP; Chetty R; Flintoft VF; Lewis S; Sykora K; Beattie DM; Fscai LS
Journal
Catheterization and Cardiovascular Interventions, Vol. 34, No. 3, pp. 210–214
Publisher
Wiley
Publication Date
3 1995
DOI
10.1002/ccd.1810340106
ISSN
1522-1946